A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs

Karen M. Kedzie, John E. Donello, Heather A. Krauss, John W Regan, Daniel W. Gil

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

A high degree of homology between the four G(s)-coupled prostaglandin (PG) receptors [EP2, EP4, prostacyclin (IP), PGD2 (DP)] and the four G(q)/G(i)-coupled receptors [EP1, EP3, PGF(2α) (FP), thromboxane A2 (TP)] suggests that prostaglandin receptors evolved functionally from an ancestral EP receptor before the development of distinct binding epitopes. If so, ligand selectivity should be determined by a limited number of amino acids. EP2 receptor transmembrane domain residues that are similar to those in the EP4 receptor but differ from those in the IP receptor wave mutated to the corresponding IP receptor residue. Activation of the mutant receptors by PGE2 (EP2 ligand), iloprost (stable prostacyclin analog), and PGE1 (EP2/IP ligand) was determined using a cAMP-dependent reporter gene assay. A Leu304-to-tyrosine substitution in the seventh transmembrane domain enhanced iloprost potency approximately 100-fold. A glycine substitution at Ser120 in the third transmembrane domain had no effect on drug potency but improved the response of the Tyr304 mutant. The potency of the natural prostaglandins PGF(2α) and PGD2 was not enhanced by the mutations. In contrast, the potency of all prostaglandins was reduced 10- to 100-fold when arginine 302, which is thought to be a counterion for the prostaglandin carboxylic acid, was mutated. Thus, a single amino acid change resulted in a selective gain of function for iloprost, which is consistent with the proposed phylogeny of the prostaglandin receptors.

Original languageEnglish (US)
Pages (from-to)584-590
Number of pages7
JournalMolecular Pharmacology
Volume54
Issue number3
StatePublished - Sep 1998

Fingerprint

Prostaglandin Receptors
Iloprost
Epoprostenol
Amino Acid Substitution
Prostaglandins
Prostaglandin D2
Prostaglandins F
Ligands
Receptors, Prostaglandin E, EP4 Subtype
Prostaglandin E Receptors
Amino Acids
Thromboxane A2
Alprostadil
Phylogeny
Carboxylic Acids
Reporter Genes
Glycine
Tyrosine
Arginine
Epitopes

ASJC Scopus subject areas

  • Pharmacology

Cite this

A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs. / Kedzie, Karen M.; Donello, John E.; Krauss, Heather A.; Regan, John W; Gil, Daniel W.

In: Molecular Pharmacology, Vol. 54, No. 3, 09.1998, p. 584-590.

Research output: Contribution to journalArticle

Kedzie, Karen M. ; Donello, John E. ; Krauss, Heather A. ; Regan, John W ; Gil, Daniel W. / A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs. In: Molecular Pharmacology. 1998 ; Vol. 54, No. 3. pp. 584-590.
@article{49486e95c1c846bd898b259c7dffe3d1,
title = "A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs",
abstract = "A high degree of homology between the four G(s)-coupled prostaglandin (PG) receptors [EP2, EP4, prostacyclin (IP), PGD2 (DP)] and the four G(q)/G(i)-coupled receptors [EP1, EP3, PGF(2α) (FP), thromboxane A2 (TP)] suggests that prostaglandin receptors evolved functionally from an ancestral EP receptor before the development of distinct binding epitopes. If so, ligand selectivity should be determined by a limited number of amino acids. EP2 receptor transmembrane domain residues that are similar to those in the EP4 receptor but differ from those in the IP receptor wave mutated to the corresponding IP receptor residue. Activation of the mutant receptors by PGE2 (EP2 ligand), iloprost (stable prostacyclin analog), and PGE1 (EP2/IP ligand) was determined using a cAMP-dependent reporter gene assay. A Leu304-to-tyrosine substitution in the seventh transmembrane domain enhanced iloprost potency approximately 100-fold. A glycine substitution at Ser120 in the third transmembrane domain had no effect on drug potency but improved the response of the Tyr304 mutant. The potency of the natural prostaglandins PGF(2α) and PGD2 was not enhanced by the mutations. In contrast, the potency of all prostaglandins was reduced 10- to 100-fold when arginine 302, which is thought to be a counterion for the prostaglandin carboxylic acid, was mutated. Thus, a single amino acid change resulted in a selective gain of function for iloprost, which is consistent with the proposed phylogeny of the prostaglandin receptors.",
author = "Kedzie, {Karen M.} and Donello, {John E.} and Krauss, {Heather A.} and Regan, {John W} and Gil, {Daniel W.}",
year = "1998",
month = "9",
language = "English (US)",
volume = "54",
pages = "584--590",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs

AU - Kedzie, Karen M.

AU - Donello, John E.

AU - Krauss, Heather A.

AU - Regan, John W

AU - Gil, Daniel W.

PY - 1998/9

Y1 - 1998/9

N2 - A high degree of homology between the four G(s)-coupled prostaglandin (PG) receptors [EP2, EP4, prostacyclin (IP), PGD2 (DP)] and the four G(q)/G(i)-coupled receptors [EP1, EP3, PGF(2α) (FP), thromboxane A2 (TP)] suggests that prostaglandin receptors evolved functionally from an ancestral EP receptor before the development of distinct binding epitopes. If so, ligand selectivity should be determined by a limited number of amino acids. EP2 receptor transmembrane domain residues that are similar to those in the EP4 receptor but differ from those in the IP receptor wave mutated to the corresponding IP receptor residue. Activation of the mutant receptors by PGE2 (EP2 ligand), iloprost (stable prostacyclin analog), and PGE1 (EP2/IP ligand) was determined using a cAMP-dependent reporter gene assay. A Leu304-to-tyrosine substitution in the seventh transmembrane domain enhanced iloprost potency approximately 100-fold. A glycine substitution at Ser120 in the third transmembrane domain had no effect on drug potency but improved the response of the Tyr304 mutant. The potency of the natural prostaglandins PGF(2α) and PGD2 was not enhanced by the mutations. In contrast, the potency of all prostaglandins was reduced 10- to 100-fold when arginine 302, which is thought to be a counterion for the prostaglandin carboxylic acid, was mutated. Thus, a single amino acid change resulted in a selective gain of function for iloprost, which is consistent with the proposed phylogeny of the prostaglandin receptors.

AB - A high degree of homology between the four G(s)-coupled prostaglandin (PG) receptors [EP2, EP4, prostacyclin (IP), PGD2 (DP)] and the four G(q)/G(i)-coupled receptors [EP1, EP3, PGF(2α) (FP), thromboxane A2 (TP)] suggests that prostaglandin receptors evolved functionally from an ancestral EP receptor before the development of distinct binding epitopes. If so, ligand selectivity should be determined by a limited number of amino acids. EP2 receptor transmembrane domain residues that are similar to those in the EP4 receptor but differ from those in the IP receptor wave mutated to the corresponding IP receptor residue. Activation of the mutant receptors by PGE2 (EP2 ligand), iloprost (stable prostacyclin analog), and PGE1 (EP2/IP ligand) was determined using a cAMP-dependent reporter gene assay. A Leu304-to-tyrosine substitution in the seventh transmembrane domain enhanced iloprost potency approximately 100-fold. A glycine substitution at Ser120 in the third transmembrane domain had no effect on drug potency but improved the response of the Tyr304 mutant. The potency of the natural prostaglandins PGF(2α) and PGD2 was not enhanced by the mutations. In contrast, the potency of all prostaglandins was reduced 10- to 100-fold when arginine 302, which is thought to be a counterion for the prostaglandin carboxylic acid, was mutated. Thus, a single amino acid change resulted in a selective gain of function for iloprost, which is consistent with the proposed phylogeny of the prostaglandin receptors.

UR - http://www.scopus.com/inward/record.url?scp=0031663772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031663772&partnerID=8YFLogxK

M3 - Article

C2 - 9730918

AN - SCOPUS:0031663772

VL - 54

SP - 584

EP - 590

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 3

ER -